lyb005
Vaccineexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jul 31, 2024 (NCT06442241)
Timeline
Indications
Mechanism of action
- Respiratory syncytial virusImmunity, active
Respiratory syncytial virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07208461 | Phase 2 | Oct 31, 2025 | Government of China |
| NCT06904222 | Phase 1 | Apr 15, 2025 | Government of China |
| NCT06442241 | Phase 1 | Jul 31, 2024 | Government of China, Nucleus Network Ltd |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Government of China | Government | 3 | 3 | 2 | 2024 |
| Nucleus Network Ltd | For profit | 1 | 0 | 1 | 2024 |
2 organizations
Page 1 / 1